Novartis on Tuesday said it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

Di first malaria treatment wey dey suitable for babies and very young children don dey approved for use.

Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global health scheme run by Swiss agency for ...

The first-ever malaria medication designed specifically for babies and young children has received approval, with plans to ...

Swiss pharmaceutical giant Novartis has received approval for Coartem Baby, the first-ever malaria treatment designed specifically for babies and young children.

Several African countries where malaria is widespread are expected to swiftly approve the new medicine following Swissmedic’s ...

Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

Novartis AG won regulatory approval for the first medicine designed for babies with malaria, the latest development in the global fight against the mosquito-borne disease.

A late-stage trial testing Novartis’ Cosentyx in individuals with giant cell arteritis failed to meet its primary endpoint. The phase 3 study tested Cosentyx alongside a 26-week steroid taper and ...

BBC - The first malaria treatment suitable for babies and very young children has been approved for use. It's expected to be ...

Xealth's "startup napkin" designed by the company for its inclusion in the "Seattle 10" program in 2017. Samsung Electronics ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.